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1. Introduction
   Kidney stone affects up to 5% of the world population[1]. 
In normal conditions; Oxalate (Ox), an end product of 
metabolism is excreted in urine. However, under certain 
pathological conditions, Ox interacts with calcium within 
the renal tubular lumen to form calcium oxalate (CaOx). In 
addition, studies show that renal cells on exposure to Ox 
and/or CaOx crystals generate reactive oxygen species (ROS), 
develop oxidative stress (OS) and associated cellular injury. 
Stone formation in the kidney, also called Nephrolithiasis 
or kidney stones, the male-to-female incidence ratio is 4:1. 
Eighty percent of calculi are composed of calcium (either 
oxalate or phosphate), with others composed of struvite, 
uric acid, or cystine[2]. Approximately 1 million Americans 
develop a kidney stone each year and an estimated 12% of 
the population forms a stone some time during their life[3]. 
Many stones are asymptomatic until they begin to move 
down the ureter, causing pain due to obstruction. The pain 
often begins suddenly when a stone moves in the urinary 
tract, causing irritation or blockage. Typically, a person 
feels a sharp, cramping pain in the back and side in the 
area of the kidney or in the lower abdomen. Sometimes 
nausea and vomiting occur[4]. Lithotripsy may be an 
alternative to surgery. In this extra-corporeal shockwave 
lithotripsy, ultrasonic waves or shockwaves are used to 
break up stones so that they may be expelled in the urine 
or removed with an endoscope. The stones, once broken, 
pass out as fine sand particles. Stones are also removed 
using cystoscopy or ureteoscopy or percutaneous surgery. 
Nowadays, about 85% of all kidney stones contain calcium 
salts (calcium oxalate and/or calcium phosphate) as their 
main crystalline components. Because human urine is 
commonly supersaturated with respect to calcium salts as 
well as to uric acid, crystalluria is very common, i.e. healthy 
people excrete up to ten millions of microcrystals every day. 
Alternatively, crystal adhesion to urothelial surfaces may be 
enhanced in stone formers[5].
2. Material and method
  The morphological studies were carried out for shape, size, 
colour, odour, taste and fracture of the polyphyto dispersible 
tablets.
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2.1. Preparation of polyherbal formulation
  Formulation was made by taking equal proportion of 
each powdered drugs. All the procured and authenticated 
individual drugs were dried in shade and cleaned by 
hand sorting. The individual drugs were then crushed 
using willing grinder and passed through mesh no. 40. The 
individual drugs were then weighed as per the quantity 
required. The drugs were mixed geometrically using a 
double cone blender. The mixed formulation was unloaded, 
weighed, and packed in labeled glass bottles[6].
2.2. Physicochemical standardization
  The various physico-chemical values of polyphyto 
combination of such as ash value, extractive values, acid 
insoluble ash, loss on drying, bulk density and true density 
pH, angle of repose  Foreign organic matter were determined 
according to the pharmacopoeial method[7,8].
2.3. Evaluation of poly-herbal dispersible tablet
2.3.1. Thickness
  The tablet thickness from each batch was measured using a 
digital vernier caliper[9].
2.3.2. Weight variation
  It is desirable that every individual tablet in a batch 
should be uniform in weight, but a small variation in the 
weight of the individual tablet is liable to occur. Therefore 
a litter variation is allowed in the weight of the tablet by 
the pharmacopoeia. The following percentage deviation in 
weight variation is allowed. 
  Weight 20 tablets selected at random and determine their 
average weight. Not more than 2 of the individual weights 
may deviate from the average weight by more than the 
percentage deviation given in the table and none should 
deviate by more than twice that percentage. 
S. No. Average weight of a tablet deviation Percentage
1. 80 mg or less 10.0
2. More than 80 mg and less than 250 mg 7.5
3. 250 mg or more 5.0
2.3.3. Dissolution test
  The test is done for measuring the amount of time required 
for a given percentage of drug substance in a tablet to go into 
solution under specified condition in vitro. The apparatus 
used for the test is as per specification given in I.P.
2.3.4. Method
  Place 1 000 mL of water which should be free from 
dissolved air and previously warmed to 36.5 曟 to 37.5 曟 
into the vessel. Place the specified number of tablets in the 
dry basket. Set the apparatus. Start the moter and adjust the 
rotation speed to 100 rpm or as directed in the monograph. 
Withdraw the stated volume of solution from the vessel after 
45 min or after the time specified in the monograph. Repeat 
the complete operation 4 times. 
  The tablets pass the test if for each of the 5 tablets; the 
amount of active ingredient is not less than 70 percent of the 
stated amount. In case were two or more tablets are directed 
to be placed together ion the basket for each test in the five 
replicate test, the amount of active ingredient in solution per 
tablet in each test should not be less than 70% of the stated 
amount or of the specified in the monograph. No re-testing 
is allowed[10]. 
2.3.5. Hardness
  Hardness for six tablets from each formulation was 
determined using Monsanto hardness tester. The Monsanto 
chemical Co. Ltd had designed spring pressure device 
to test the hardness of a tablet. It has a graduated scale 
which gives the reading in kg/cm2. The tablet to be tested 
is placed between the spindle and the anvil. The desired 
pressure needed to hold the tablet in position is applied by 
moving the screw knob in clockwise direction. The scale is 
moved so that the indicator is fixed at zero. The pressure 
is then applied till the tablet breaks. The reading is noted, 
which indicates the pressure which is needed to break the 
tablet[11].
2.3.6. Friability test
  Normally during the course of tablets a sufficient pressure 
is applied on the granules, so that the tablets can withstand 
the wear and tear during transportation and handling. But 
in spite of observing all the precautions, the tablets show 
considerable powdering after normal handling, giving an 
undesirable appearance. Friability test is performed to 
evaluate the ability of the tablet to withstand wear and tear 
in packing, handling and transporting. The apparatus used 
to perform this test is known as “friability. 
  The apparatus consists of a plastic chamber, which is 
divided into two parts and it revolves at a speed of 25 r.p.m. 
twenty tablets are weigh and placed in the plastic chamber. 
The chamber is rotated for 4 min or 100 revolutions. During 
each revolution the tablet falls from a distance of 6 inch. The 
tablets are removed for the chamber after 100 revolutions 
and weighed. Loss in weight indicates the friability. The 
tablets are considered to be of good quality if the loss in 
weight is less than 0.8%[12].
2.3.7. Bulk density
  A powder is passed through a standard sieve No. 20. A 
weighed amount is introduced into a 100 mL graduated 
cylinder. The cylinder is fixed on the bulk density 
apparatus and the timer knob is set for 100 tappings. The 
volume occupied by the powder is noted. Further another 
50 taps may be continued and the final volume is noted. 
For reproducible results, the process of tapings may be 
continued until concurrent volume is achieved. The final 
volume is the bulk volume. Then bulk density is calculated 
using equation[13].
Bulk Density = Weight of the sample / bulk volume
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3. Result 
3.1. Macroscopical evaluation
  The polyphyto combinations were subjected to 
macroscopical examination and observations were recorded. 
The proper examination of the polyphyto combinations was 
carried out under sun light and artificial source similar to 
day light.
3.2. Description
a) Colour: Light brown
b) Odour: Characterstics
c) Taste: Bitter
3.3. Physico-chemical parameters
a) Loss on drying at 105 曟:  6 % w/w
b) Total-ash: 9 g
c) Acid insoluble ash: 32% w/w
d) Alcohol soluble extractive: 10.6% w/w
e) Water soluble extractive: 50.4% w/w
f) Chloroform soluble extractive: 11.6% w/w
g) pH: 7
h) Bulk density: 2 g/mL
i) True density: 0.001 g/mL
j) Angle of repose: tan-1 (0.32)
k) Foreign organic matter: 62.9 % w/w
Table 1
Phytochemical screening.
S.N. Phytochemical test Aqueous extract
1. Alkaloids +++ Present
2. Tannins ---Absent
3. Glycoside
a Saponin --- Absent
b Flavanoids --- Absent
c Steroids ++ Present
4. Protein +++ Present
Table 2
Quantitative evaluation of tablet from of drugs.
S.N. Parameter Observed data formulation
1. Disintegration time 29 s
2. Hardness 3 kg/cm2
3. Weight variation 248依10
4. Friability 1%
4. Discussion
  The use of the herbals as medicine is an age old tradition 
which will serve as a source of alternative medicine in future 
also and help to overcome the toxic effects of the synthetic 
drugs. The results have come out to be very motivating 
and further pharmacological study could be carried out on 
the samples to reveal an effective drug for the urolithiasis. 
Data reveals that phytotherapeutic agents could be useful 
as either an alternative or a complementary therapy in the 
management of urolithiasis.
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